Provenance du réseau au premier degré de Pavel Khrimian
Entité | Type d'entité | Industrie | |
---|---|---|---|
Deka Biosciences, Inc.
Deka Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Deka Biosciences, Inc. is a biotech company based in Germantown, MD. Deka Biosciences is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases. The company has developed disease-specific diakines™ that are designed to maximize patient benefits through improved pharmacokinetics/pharmacodynamics function by the targeted accumulation of dual and complimentary cytokines into affected tissues. Deka Biosciences aims to build specific targeted therapies for everyone by developing a better understanding of each patient's immune response to different diakines™. The company was founded in 2019 by John B. Mumm and Pavel Khrimian, with John B. Mumm serving as the CEO since then.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Pavel Khrimian via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Aerogel Corp.
American Aerogel Corp. Chemicals: Major DiversifiedProcess Industries American Aerogel Corp. develops and manufactures aerogel-based insulation products. It provides cold-chain design, implementation, and shipping services. The company was founded by Robert S. Mendenhall, Dennis Young, and Greg R. Andrews in 2013 and is headquartered in Rochester, NY. | Chemicals: Major Diversified | Director/Board Member | |
Bacterial Barcodes, Inc.
Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Medical Specialties | Corporate Officer/Principal | |
ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Founder | |
NewSpring Healthcare
NewSpring Healthcare Investment ManagersFinance NewSpring Healthcare is the venture capital/private equity operating health care division of NewSpring Capital LLC founded in 1999. The firm is headquartered in Radnor, Pennsylvania. | Investment Managers | Consultant / Advisor | |
Salisbury State University | College/University | Undergraduate Degree | |
LumaCyte LLC
LumaCyte LLC Miscellaneous Commercial ServicesCommercial Services LumaCyte LLC is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation. The company is based in Charlottesville, VA. LumaCyte's revolutionary technology utilizes laser force cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel, quantitatively characterizing innate cellular responses of subtle phenotypic changes based purely on the intrinsic biophysical and biochemical properties of cells. The univariate and multivariate nature of the data has enabled a host of big data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell-based biological systems. The company was founded in 2012, and the CEO is Sean J. Hart. | Miscellaneous Commercial Services | Director/Board Member | |
CATALENT, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Biotechnology | Chief Executive Officer | |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Stanford University | College/University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 16 |
Afrique du Sud | 2 |
Sectorielle
Health Technology | 9 |
Commercial Services | 5 |
Consumer Services | 3 |
Process Industries | 2 |
Finance | 2 |
Opérationnelle
Corporate Officer/Principal | 8 |
Director/Board Member | 6 |
Director of Finance/CFO | 2 |
Chief Executive Officer | 2 |
Chief Operating Officer | 2 |
Relations les plus connectées
Insiders | |
---|---|
Peter Buzy | 12 |
John B. Mumm | 7 |
John Conner | 1 |
- Bourse
- Insiders
- Pavel Khrimian
- Connexions Sociétés